Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
10.97
-0.33 (-2.92%)
At close: Aug 20, 2025, 4:00 PM
11.32
+0.35 (3.19%)
Pre-market: Aug 21, 2025, 4:11 AM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.94 billion as of August 20, 2025. Its market cap has increased by 2.55% in one year.
Market Cap
3.94B
Enterprise Value
4.15B
1-Year Change
2.55%
Ranking
Category
Stock Price
10.97
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.94B, an increase of 3,319.35%. That is a compound annual growth rate of 57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 3.68B | -27.72% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | 817.72M | 196.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |